ITS BIO

AffinityImmuno Products

ELISA kits, research antibodies, biosimilars and isotype controls from AffinityImmuno.

EL-213-1616

EL-213-1616 image 1

AffinityImmuno · ELISA Kit

Human p16INK4a ELISA Kit

Cat.No

EL-213-1616

96 wells

Reactivity
Human
Detection range
0.63-40 ng/mL
Sample type
tissue homogenates, cell lysates and other biological fluids
Assay time
3h 20min

Product Overview

Introduction

CDKN2A is a locus that, through use of alternate first exons, gives rise to more than one distinct protein, the best known of which is p16INK4a. p16INK4a works as a brake on cell division by physically attaching to the cyclin-dependent kinases CDK4 and CDK6, blocking them from teaming up with cyclin D and thereby stopping them from inactivating the retinoblastoma protein, a step normally required for a cell to pass from G1 into S phase. Its levels climb as cells accumulate DNA damage or oncogenic stress, making p16INK4a one of the principal drivers that pushes a cell into permanent growth arrest, or senescence, rather than continued division, and it is used as a molecular marker of that senescent state and of tissue aging more broadly. Because this brake is so central to preventing uncontrolled proliferation, the CDKN2A locus is one of the most frequently deleted, mutated, or silenced regions in human cancer, and inherited defects in it underlie hereditary melanoma and related melanoma-pancreatic cancer predisposition syndromes.

p16INK4a is the field’s standard marker for identifying senescent cells, and landmark studies showing that clearing p16INK4a-positive cells delays aging-associated disorders have made it central to the rapidly growing senolytic and longevity-therapeutics research space, alongside its long-established role as one of the most frequently altered tumor suppressors in cancer.

Principle of the Assay

This sandwich enzyme immunoassay utilizes a microtiter plate pre-coated with a capture antibody specific to human p16INK4a (CDKN2A). During the first incubation, p16INK4a present in standards or samples is captured by this immobilized antibody. A biotin-conjugated secondary antibody, also specific to human p16INK4a, is then added and binds a distinct epitope on the captured analyte, forming a sandwich complex. Avidin conjugated to horseradish peroxidase (HRP) is subsequently added to each well, where it binds the biotin moiety. Following addition of TMB substrate, only wells containing the complete sandwich complex — captured p16INK4a, biotin-conjugated detection antibody, and avidin-HRP — develop a colorimetric signal. The enzymatic reaction is terminated by addition of a sulphuric acid stop solution, and absorbance is measured at 450 nm (± 10 nm). p16INK4a concentrations in unknown samples are determined by interpolating their absorbance values against a standard curve.

Need assistance?
Contact our experts for support and fast quotations.
(주)이츠바이오
07532 서울특별시 강서구 양천로 551-17 한화비즈메트로 1차 812호
T : 02-3462-8658  F : 02-3462-8659
E-mail : info@itsbio.co.kr
ITSBio, Inc.
812, Hanwha Bizmetro A-dong, 551-17 YangcheonRo, Gangseo-Gu, Seoul, 07532, Korea, Republic of
T : +82-2-3462-8658  F : +82-2-3462-8659
E-mail : info@itsbio.co.kr
Privacy Policy|Terms|© 2026 ITS BIO. All rights reserved.
Online Message
Send to info@itsbio.co.kr